Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Docetaxel Extravasation Causing Significant Delayed Tissue InjuryGynecologic oncology, 2000-08, Vol.78 (2), p.259-260 [Peer Reviewed Journal]2000 Academic Press ;2000 INIST-CNRS ;Copyright 2000 Academic Press. ;ISSN: 0090-8258 ;EISSN: 1095-6859 ;DOI: 10.1006/gyno.2000.5873 ;PMID: 10926814 ;CODEN: GYNOA3Full text available |
|
2 |
Material Type: Article
|
Cervical Cancer Immunotherapy: Facts and HopesClinical cancer research, 2021-09, Vol.27 (18), p.4953-4973 [Peer Reviewed Journal]2021 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-20-2833 ;PMID: 33888488Full text available |
|
3 |
Material Type: Article
|
Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline UpdateJournal of clinical oncology, 2018-07, Vol.36 (19), p.1994-2001 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2018.78.1914 ;PMID: 29620997Full text available |
|
4 |
Material Type: Article
|
Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice GuidelinesAnnals of oncology, 2020-12, Vol.31 (12), p.1664-1678 [Peer Reviewed Journal]2020 European Society for Medical Oncology ;ISSN: 0923-7534 ;ISSN: 1569-8041 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2020.09.006 ;PMID: 32976936Full text available |
|
5 |
Material Type: Article
|
Stearoyl-CoA Desaturase 1 Protects Ovarian Cancer Cells from Ferroptotic Cell DeathCancer research (Chicago, Ill.), 2019-10, Vol.79 (20), p.5355-5366 [Peer Reviewed Journal]2019 American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.can-19-0369 ;PMID: 31270077Full text available |
|
6 |
Material Type: Article
|
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014Annals of oncology, 2015-02, Vol.26 (2), p.259-271 [Peer Reviewed Journal]2014 European Society for Medical Oncology ;The Author 2014. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;The Author 2014. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2014 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdu450 ;PMID: 25214542Full text available |
|
7 |
Material Type: Article
|
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNAAnnals of oncology, 2020-06, Vol.31 (6), p.745-759 [Peer Reviewed Journal]2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2020.02.011 ;PMID: 33506766Full text available |
|
8 |
Material Type: Article
|
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized TrialJournal of clinical oncology, 2020-09, Vol.38 (25), p.2830-2838 [Peer Reviewed Journal]2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.20.00818 ;PMID: 32484754Full text available |
|
9 |
Material Type: Article
|
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline UpdateJournal of clinical oncology, 2020-04, Vol.38 (12), p.1346-1366 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.19.02309 ;PMID: 31928404Full text available |
|
10 |
Material Type: Article
|
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021Annals of oncology, 2021-10, Vol.32 (10), p.1216-1235 [Peer Reviewed Journal]2021 ;Copyright © 2021. Published by Elsevier Ltd. ;2021 Published by Elsevier Ltd on behalf of European Society for Medical Oncology. 2021 ;ISSN: 0923-7534 ;ISSN: 1569-8041 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2021.06.023 ;PMID: 34242744Full text available |
|
11 |
Material Type: Article
|
Current and future burden of breast cancer: Global statistics for 2020 and 2040Breast (Edinburgh), 2022-12, Vol.66, p.15-23 [Peer Reviewed Journal]2022 World Health Organization ;Copyright © 2022 World Health Organization. Published by Elsevier Ltd.. All rights reserved. ;2022 World Health Organization. Published by Elsevier Ltd. 2022 ;ISSN: 0960-9776 ;EISSN: 1532-3080 ;DOI: 10.1016/j.breast.2022.08.010 ;PMID: 36084384Full text available |
|
12 |
Material Type: Article
|
Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA ProfilingCancer discovery, 2017-12, Vol.7 (12), p.1394-14032017 American Association for Cancer Research. ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.cd-17-0716 ;PMID: 28899864Full text available |
|
13 |
Material Type: Article
|
ESO–ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)Annals of oncology, 2020-06, Vol.31 (6), p.674-696 [Peer Reviewed Journal]2020 European Society for Medical Oncology ;Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. ;ISSN: 0923-7534 ;ISSN: 1569-8041 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2020.03.284 ;PMID: 32199930Full text available |
|
14 |
Material Type: Article
|
Treatment landscape of triple-negative breast cancer - expanded options, evolving needsNature reviews. Clinical oncology, 2022-02, Vol.19 (2), p.91-113 [Peer Reviewed Journal]2021. Springer Nature Limited. ;Springer Nature Limited 2021. ;ISSN: 1759-4774 ;EISSN: 1759-4782 ;DOI: 10.1038/s41571-021-00565-2 ;PMID: 34754128Full text available |
|
15 |
Material Type: Article
|
Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With CancerJournal of clinical oncology, 2016-07, Vol.34 (20), p.2366-2371 [Peer Reviewed Journal]2016 by American Society of Clinical Oncology. ;2016 by American Society of Clinical Oncology 2016 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2015.65.4327 ;PMID: 27185838Full text available |
|
16 |
Material Type: Article
|
Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology GuidelineJournal of clinical oncology, 2016-09, Vol.34 (25), p.3069-3103 [Peer Reviewed Journal]2016 by American Society of Clinical Oncology. ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2016.67.1487 ;PMID: 27217461Full text available |
|
17 |
Material Type: Article
|
Cancer statistics, 2023CA: a cancer journal for clinicians, 2023-01, Vol.73 (1), p.17-48 [Peer Reviewed Journal]2023 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Jan/Feb 2023 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21763 ;PMID: 36633525Full text available |
|
18 |
Material Type: Article
|
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II StudyJournal of clinical oncology, 2021-09, Vol.39 (27), p.2991-3001 [Peer Reviewed Journal]2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.03555 ;PMID: 34292792Full text available |
|
19 |
Material Type: Article
|
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic SyndromesJournal of clinical oncology, 2021-04, Vol.39 (11), p.1223-1233 [Peer Reviewed Journal]2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.20.01659 ;PMID: 33539200Full text available |
|
20 |
Material Type: Article
|
Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic MelanomaJournal of clinical oncology, 2021-08, Vol.39 (24), p.2656-2666 [Peer Reviewed Journal]2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.21.00612 ;PMID: 33979178Full text available |